Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

81 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
High-dose infliximab prophylaxis in endotoxin-induced uveitis.
Diaz-Llopis M, García-Delpech S, Salom D, Udaondo P, Bosch-Morell F, Quijada A, Romero FJ, Amselem L. Diaz-Llopis M, et al. Among authors: udaondo p. J Ocul Pharmacol Ther. 2007 Aug;23(4):343-50. doi: 10.1089/jop.2006.0148. J Ocul Pharmacol Ther. 2007. PMID: 17803432
[Rebound tonometry vs Goldmann vs Neumotonometer].
Díaz-Llopis M, García-Delpech S, Udaondo P. Díaz-Llopis M, et al. Among authors: udaondo p. Arch Soc Esp Oftalmol. 2007 Oct;82(10):607-8; author reply 608. doi: 10.4321/s0365-66912007001000003. Arch Soc Esp Oftalmol. 2007. PMID: 17929202 Spanish. No abstract available.
Adalimumab therapy for refractory uveitis: a pilot study.
Diaz-Llopis M, García-Delpech S, Salom D, Udaondo P, Hernández-Garfella M, Bosch-Morell F, Quijada A, Romero FJ. Diaz-Llopis M, et al. Among authors: udaondo p. J Ocul Pharmacol Ther. 2008 Jun;24(3):351-61. doi: 10.1089/jop.2007.0104. J Ocul Pharmacol Ther. 2008. PMID: 18476805 Clinical Trial.
81 results